市場調查報告書
商品編碼
1562238
中東和非洲近視治療市場預測至 2030 年 - 區域分析 - 按類型、治療、年齡層和最終用戶Middle East & Africa Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User |
2022年中東和非洲近視治療市場價值為2.633億美元,預計到2030年將達到4.6581億美元;預計2022年至2030年複合年成長率為7.4%。
人工智慧在近視治療的應用提振中東和非洲近視治療市場
人工智慧(AI)擴大應用於近視治療。一個例子是使用人工智慧設備來監測和分析眼球運動和視力,這可以幫助識別近視的早期跡象並追蹤其進展。人工智慧演算法還可用於根據患者的特徵和病史制定個人化的治療計劃。未來,人工智慧有望在近視治療中發揮更大作用。例如,研究人員正在探索使用機器學習演算法來預測近視高風險兒童,從而進行早期介入和預防。
此外,人工智慧驅動的虛擬實境系統可以提高視力並減少近視加深。因此,近視治療市場預計在未來幾年將持續成長和創新。隨著全球近視盛行率的不斷上升,對有效且易於使用的治療方法的需求日益成長。人工智慧和先進手術技術等技術進步預計將推動這一成長,並帶來更個人化和有效的近視治療。此外,人們可能會更加關注預防措施以及工業界和學術界之間的合作,以解決這個全球健康問題。
中東和非洲近視治療市場概況
中東和北非由三個主要國家組成:阿拉伯聯合大公國(阿拉伯聯合大公國)、沙烏地阿拉伯和南非。阿拉伯聯合大公國是最大的近視治療市場。該市場的促進因素包括眼部疾病發病率的增加、消費者近視意識的增強以及國際企業在該地區滲透率的提高。
沙烏地阿拉伯在改善眼睛健康方面取得了長足進步。根據世界衛生組織的數據,沙烏地阿拉伯約有 8,000 名兒童患有功能性低視力。先天性青光眼是該國兒童失明的主要原因之一。此外,在預測期內,電腦和智慧型手機的使用不斷增加,創造了對眼部補充劑的需求。預防失明和耳聾已被納入沙烏地阿拉伯新的初級衛生保健政策。為了保持眼部保健的連續性,現有衛生機構正在製定一項為期 5-10 年的計劃,其中包括早產兒視網膜病變 (ROP)、學齡前視力、糖尿病視網膜病變、青光眼和白內障的篩檢。衛生部正在全國另外設立四個眼科中心來提供這些服務。因此,該國政府正在實施運動和社區教育計劃,這是眼睛健康促進策略的影響因素。這些策略有助於提高意識並鼓勵社區承擔起眼睛健康的責任。該行動進一步加強了現有眼部保健服務的適當利用。例如,衛生部 (MoH) 提供有關眼部疾病的教育資訊。這有助於教育人們有關青光眼、近視、弱視、糖尿病視網膜病變和隱形眼鏡的知識。因此,上述因素預計將為未來幾年近視治療市場的成長提供有利可圖的機會。
中東和非洲近視治療市場收入及 2030 年預測(百萬美元)
中東和非洲近視治療市場細分
中東和非洲近視治療市場按類型、治療、年齡層、最終用戶和國家分類。
根據類型,中東和非洲近視治療市場分為高度近視、退化性近視和進行性近視。 2022 年,高度近視細分市場佔據中東和非洲近視治療市場最大佔有率。
在治療方面,中東和非洲近視治療市場分為低劑量阿托品眼藥水、隱形眼鏡、角膜塑形鏡和屈光手術。到2022年,低劑量阿托品眼藥水區隔市場將佔據中東和非洲近視治療市場最大佔有率。
依年齡層別分類,中東和非洲近視治療市場分為成人近視和兒童近視。 2022 年,成人近視細分市場在中東和非洲近視治療市場中佔有更大佔有率。
根據最終用戶,中東和非洲近視治療市場分為醫院和診所、專科診所和屈光手術中心。 2022 年,醫院和診所細分市場佔據中東和非洲近視治療市場最大佔有率。
依國家分類,中東和非洲近視治療市場分為沙烏地阿拉伯、阿拉伯聯合大公國、南非以及中東和非洲其他地區。 2022年,沙烏地阿拉伯在中東和非洲近視治療市場佔有率中佔據主導地位。
Alcon AG、Bausch Health Companies Inc、Carl Zeiss AG、CooperVision Inc、Johnson & Johnson Vision Care Inc 和 Nidek Co Ltd 是中東和非洲近視治療市場上的一些領先公司。
The Middle East & Africa myopia treatment market was valued at US$ 263.30 million in 2022 and is expected to reach US$ 465.81 million by 2030; it is estimated to register a CAGR of 7.4% from 2022 to 2030.
Application of Artificial Intelligence in Myopia Treatment bolsters Middle East & Africa Myopia Treatment Market
Artificial intelligence (AI) is increasingly being applied in myopia treatment. One example is using AI-powered devices to monitor and analyze eye movements and visual acuity, which can help identify early signs of myopia and track its progression. AI algorithms can also be used to develop personalized patient treatment plans based on their characteristics and medical history. In the future, AI is expected to play an even greater role in myopia treatment. For instance, researchers are exploring the use of machine learning algorithms to predict children who are at high risk of developing myopia, allowing for early intervention and prevention.
Additionally, AI-powered virtual reality systems may improve visual acuity and reduce myopia progression. Thus, the myopia treatment market is expected to see continued growth and innovation in the coming years. With the increasing prevalence of myopia worldwide, there is a growing need for effective and accessible treatments. Advancements in technology, such as AI and advanced surgical techniques, are expected to drive this growth and lead to more personalized and effective treatments for myopia. Additionally, there will likely be a greater focus on preventative measures and collaboration between industry and academia to address this global health concern.
Middle East & Africa Myopia Treatment Market Overview
Middle East & North Africa consists of three major countries: United Arab Emirates (UAE), Saudi Arabia and South Africa. UAE is the largest market for myopia treatment. The market is driven by increasing incidences of eye disorders, growing consumer awareness of myopia, and increasing penetration of international players in the region.
Saudi Arabia has made great strides in improving eye health. As per the WHO, around 8,000 children have functional low vision in Saudi Arabia. Congenital glaucoma is among the leading cause of childhood blindness in the country. Moreover, the increasing use of computers and smartphones creates demand for eye supplements during the forecast period. Prevention of blindness and deafness has been incorporated into Saudi Arabia's new primary health care policy. To maintain a continuum of eye care, a 5-10-year program that encompasses screening for Retinopathy of Prematurity (ROP), preschool vision, diabetic retinopathy, glaucoma, and cataracts is being developed within existing health structures. The MOH is establishing four additional eye centers nationwide to deliver these services. Therefore, the government in the country is implementing campaigns and community-based education programs, which are influential elements for eye health promotion strategies. The strategies help raise awareness and encourage the community to take responsibility for eye health. The action further enforces the appropriate employment of the available eye care services. For instance, the Ministry of Health (MoH) provides educational messages on eye diseases. This helps educate people about glaucoma, myopia, amblyopia, diabetic retinopathy, and contact lenses. Thus, the abovementioned factors are expected to offer lucrative opportunities for the myopia treatment market growth in the coming years.
Middle East & Africa Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Myopia Treatment Market Segmentation
The Middle East & Africa myopia treatment market is categorized into type, treatment, age group, end user, and country.
Based on type, the Middle East & Africa myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Middle East & Africa myopia treatment market share in 2022.
In terms of treatment, the Middle East & Africa myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Middle East & Africa myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the Middle East & Africa myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Middle East & Africa myopia treatment market share in 2022.
Based on end user, the Middle East & Africa myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Middle East & Africa myopia treatment market share in 2022.
Based on country, the Middle East & Africa myopia treatment market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa myopia treatment market share in 2022.
Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, and Nidek Co Ltd are some of the leading companies operating in the Middle East & Africa myopia treatment market.